The Brain Galanin Receptors: Targets for Novel Antidepressant Drugs

E-ISSN： 1996-3181|6|3|183-192

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.6, Iss.3, 2007-06, pp. : 183-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of antidepressant drugs administered repeatedly on the dopamine D 3 receptors in the rat brain

By Maj J. Dziedzicka-Wasylewska M. Rogoz R. Rogoz Z.

European Journal of Pharmacology, Vol. 351, Iss. 1, 1998-06 ,pp. : 31-37

Elsevier

Access to resources Recommend Favorite

Novel Targets for Drugs in Schizophrenia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 265-272

Bentham Science Publishers

Access to resources Recommend Favorite

Neurobiology of Depression and Novel Antidepressant Drug Targets

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-12 ,pp. : 5791-5801

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to Tuberculosis – Novel Drugs Based on Drug Targets Related to Toll-Like Receptors in Macrophages

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4404-4417

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin-Dopamine Interaction as a Focus of Novel Antidepressant Drugs

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 177-185

Bentham Science Publishers

Access to resources Recommend Favorite